Cell Point SME IPO To Open On June 15, 2023: Should You Subscribe?

Leading smartphone and electronics retailer Cell Point India is getting ready to launch its Initial Public Offering (IPO) and enter the stock market by raising an amount of Rs. 50.34 crores. A fresh issuance of 5,034,000 shares will be made available during the IPO, which commences on June 15 and ends on June 20, at a fixed price of Rs. 100 per equity share. On June 29, 2023, the listing is expected to be listed on the NSE Emerge platform. Cell Point India is supported by competent financial specialists thanks to First Overseas Capital Ltd. as the lead manager and Bigshares Services Pvt. Ltd. as the IPO registrar.

The lot size of Cell Point SME IPO is fixed at 1200 shares hence retail investors are required to make a minimum investment of Rs 1.20 lakh for subscription. Cell Point (India) SME IPO Allotment Date is 23-06-2023.

The IPO presents a promising investment opportunity for those seeking long-term gains in the dynamic smartphone industry, says analyst Nikhil Bhatt in his Research report. With a strong track record of growth, strategic partnerships, and a wide range of products, Cell Point India is poised for success in the market, the SEBI registered analyst further said.

As per the market observers, Cell Point IPO grey market premium (GMP) today is Rs 11, which means grey market is expecting that Cell Point IPO listing price would be around Rs 111 per equity share ( Rs100 + Rs11), which means the lucky allottees getting company shares on Cell Point IPO allotment date may expect around 11 per cent listing gain on Cell Point IPO listing date, which is most likely on 29th June 2023.

"Cell Point India IPO presents an appealing investment opportunity for those seeking long-term gains. With a solid foundation, visionary leadership, and a commitment to customer satisfaction, Cell Point India is poised to capitalise on the growing demand for smartphones and related products. Invest wisely and secure your position in this dynamic industry," said Nikhil Bhatt.

Considering the positive financial performance and growth potential of Cell Point India, coupled with its strong presence in the mobile retail industry, investors are encouraged to apply for long-term gains, says SEBI Registered analyst Nikhil Bhatt. The company's remarkable progress over the past three years, with substantial growth in total assets, revenue, and profit after tax, showcases its ability to enhance profitability while expanding operations, he further added.

"Cell Point India's IPO proceeds will be utilised to repay borrowings, repair and renovate existing retail outlets, set up new stores, meet working capital requirements, cover general corporate expenses, and allocate funds for issue expenses. These strategic allocations aim to reduce debt, improve retail outlets, support operations, and ensure a successful IPO," said SEBI Registered analyst Nikhil Bhatt.

In Visakhapatnam, Andhra Pradesh, Mr. Mohan Prasad Panday and Mr. Bala Balaji Panday established Cell Point India, a start-up mobile retail company that has now expanded into a network of over 75 retail locations. Retailing smartphones, tablets, mobile accessories, and related products from well-known companies is the company's main focus. Through strategic partnerships with top smartphone manufacturers like Oppo, Vivo, Xiaomi, Realme, and more, Cell Point India enjoys exclusive rights and can offer quality products at competitive prices.

Disclaimer

The recommendations made above are by market analysts and are not advised by either the author, nor Greynium Information Technologies. The author, nor the brokerage firm nor Greynium would be liable for any losses caused as a result of decisions based on this write-up. Goodreturns.in advises users to consult with certified experts before making any investment decision.